Clinical trialNCT06141564Active, not recruitingObservational

Detect and Expunge Concealed Tumors of the Liver

SponsorJohns Hopkins UniversityEnrollment360Liver Cancer

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The investigators long-term goal is to identify molecular and immunological signatures that can be used as biomarkers to accurately predict early recurrence and inform immunotherapeutic strategies in patients with hepatocellular carcinoma (HCC) after hepatectomy. As an initial step toward this long-term investigation, represented by this proposal, the investigators aim to comprehensively and globally describe the patterns of autoantibody expressions, the possible role in disease outcomes, and the relationship between these autoantibodies to tumor-specific/tumor-associated antigens by histologic examination as well as to peripheral immune characteristics in HCC patients with or without recurrence after surgery.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Binh T Mai, MD, PhD
The 108 Military Central Hospital
Principal Investigator
clinicaltrials.gov ↗
Chi V Dang, MD, PhD
Johns Hopkins University
Principal Investigator
clinicaltrials.gov ↗
Doan Dao, MD
Johns Hopkins School of Medicine
Principal Investigator
clinicaltrials.gov ↗
Heng Zhu, PhD
Johns Hopkins University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Vietnam

108 Military Central Hospital
Hanoi, Vietnam

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 16 Oct 2023
Primary completion: 31 Oct 2026
Completion: 31 Dec 2026
Last update posted: 18 Nov 2025
Registered enrollment: 360
Registry id: NCT06141564

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.